In support of life-saving breast cancer research, Aveo plans to reach their goal of raising $1 million in 2019.
As part of our commitment to older Australians, in 2016 Aveo formed a partnership with the PA Research Foundation, home to the discovery of the world’s first cancer vaccine. This national partnership involves working closely together to raise much-needed funds through the breast cancer campaign Project Pink, to invest back into life-saving medical research projects. We have raised over $700,000 to date, but we still have much more to do in order to reach our goal of $1 million.
Our communities coming together
Residents, staff and partners across our offices and 94 communities have rallied together to raise funds to support UQ Diamantina Institute Group Leader Dr Fiona Simpson and her lab’s ground-breaking research project – a world-first treatment option for triple negative breast cancer patients.
Thanks to the support from Aveo, phase-one clinical trials are nearly complete with only two more patients to undergo the new combination therapy of cetuximab and stemetil.
It has been quite a journey for all the patients in the phase-one trails, but the end is in sight, and once further larger commercial investment is secured, phase-two trials will then roll-out nationwide.
As our principles become aligned in transforming lives through increased health and wellbeing, Aveo are supporting ‘Project Pink’ again in 2019 throughout October, which is Breast Cancer Awareness month.
Our Aveo communities are united by the cause and there will be no shortage of pink again as a variety of events will be hosted from art shows, fun runs, high teas and pink lunches in order to meet our 2019 fundraising goal.
The next real need for breast cancer research has been identified within the new Metro South Health Breast Cancer Institute, which is now underway at the PA Hospital Campus. Moving forward, all Aveo funds raised in 2019 will be distributed towards this Institute, which is a combination of clinical practice and breast cancer research.
PARF are supporting, thanks to Aveo’s funds raised this year, the research component of the institute, which is largely looking into breast cancer imaging and mammographic density to aid with better diagnosis’ and treatment options for those faced with the disease.
For more information visit the Project Pink Website.